C

C3i

70 employees

Centre for Commercialization of Cancer Immunotherapy is to Accelerate the discovery, commercialization, and access to Cancer Immunotherapy.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
regenerative medicine
Networking
Life Science
Commercialisation
Stem cells
Clinical Research
cGMP Cell Manufacturing
Health Care
Oncology
Diagnostics
Cancer Immunotherapy
Innovation
Biomarkers
Cell and Gene Therapy

Date founded

2016

Investments made

I

Inspire Biotherapeutics Inc raised undisclosed on March 15, 2023

Investors: Octane, Ontario Institute for Regenerative Medicine and C3i

FAQ